Evidence map›Paper›PMID 38696340›Full record

Trial reportAnesthesiology2024

Addition of Liposomal Bupivacaine to Standard Bupivacaine versus Standard Bupivacaine Alone in the Supraclavicular Brachial Plexus Block: A Randomized Controlled Trial.

Timmy Chi Wing Chan, Janus Siu Him Wong, Fengfeng Wang, Christian Xinshuo Fang, Colin Shing-Yat Yung, Manson Tak Hei Chan, Will Shing Him Chan, Stanley Sau Ching Wong

2 registry-linked trialsAbstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Anesthesiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07587203 naenrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Effect of Liposomal Bupivacaine and Bupivacaine Hydrochloride for Superior Trunk Block of the Interscalene Brachial Plexus on Postoperative Diaphragmatic Function and Analgesia in Shoulder Surgery: A Multicenter, Randomized Controlled Study

TypeinterventionalSponsorNanjing First Hospital, Nanjing Medical UniversityRan2026 to 2027Enrolled184ConditionsProximal Humerus Surgery, Rotator Cuff Surgery, Shoulder Arthroplasty, Shoulder ArthroscopyArmsLiposomal bupivacaine, Bupivacaine Hydrochloride
NCT07643792 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery: a Randomized Trial

TypeinterventionalSponsorPeking University First HospitalRan2026 to 2028Enrolled148ConditionsFascia Iliaca Block, Liposomal Bupivacaine, Postoperative Pain, Hip SurgeryArmsLiposomal bupivacaine (LB), Plain bupivacaine
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Comparison of Liposomal Bupivacaine versus Bupivacaine in Superficial Parasternal Intercostal Plane Block for Cardiac Surgery with Median Sternotomy.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2025
    Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Timmy Chi Wing ChanDepartment of Anaesthesiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China; Department of Anaesthesia, Pain & Perioperative Medicine, Queen Mary Hospital, Hong Kong, China.
Janus Siu Him WongDepartment of Orthopaedics and Traumatology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.ORCID 0000-0003-1361-4733
Fengfeng WangDepartment of Anaesthesiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Christian Xinshuo FangDepartment of Orthopaedics and Traumatology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.ORCID 0000-0002-3827-0351
Colin Shing-Yat YungDepartment of Orthopaedics and Traumatology, Queen Mary Hospital, Hong Kong, China.ORCID 0000-0003-2624-3441
Manson Tak Hei ChanDepartment of Anaesthesia, Pain & Perioperative Medicine, Queen Mary Hospital, Hong Kong, China.
Will Shing Him ChanDepartment of Anaesthesia, Pain & Perioperative Medicine, Queen Mary Hospital, Hong Kong, China.
Stanley Sau Ching WongDepartment of Anaesthesiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.ORCID 0000-0002-8763-5687

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe analgesic effect of adding liposomal bupivacaine to standard bupivacaine in supraclavicular brachial plexus block is not known. The authors hypothesized that addition of liposomal bupivacaine would reduce acute postoperative pain compared to standard bupivacaine alone.

methodsA randomized controlled trial was conducted. Patients and outcome assessors were blinded. Eighty patients undergoing distal radial fracture fixation during regional anesthesia with supraclavicular brachial plexus block were randomized into two groups. The liposomal bupivacaine group received 10 ml 0.5% plain bupivacaine immediately followed by 10 ml 1.33% liposomal bupivacaine (n = 40). The standard bupivacaine group received 20 ml 0.5% plain bupivacaine (n = 40). The primary outcome was weighted area under curve (AUC) numerical rating scale pain score at rest during the first 48 h after surgery. Secondary outcomes included weighted AUC scores for pain with movement, overall benefit with analgesia score, and other functional scores.

resultsFor the primary outcome, the liposomal bupivacaine group was associated with statistically significantly lower weighted AUC pain score at rest (0.6 vs. 1.4; P < 0.001) in the first 48 h. Of the secondary outcomes, no difference between treatment groups reached statistical significance with the exception of weighted AUC score for pain with movement (2.3 vs. 3.7; adjusted P < 0.001) and overall benefit with analgesia score (1.1 vs. 1.7; adjusted P = 0.020) in the first 48 h, as well as numerical rating scale pain score at rest (0.5 vs. 1.9; adjusted P < 0.001) and with movement (2.7 vs. 4.9; adjusted P < 0.001) on postoperative day 1. Differences in numerical rating scale pain scores on postoperative days 2, 3, and 4 did not reach the level of statistical significance. There were no statistically significant differences in sensory function.

conclusionsLiposomal bupivacaine given via supraclavicular brachial plexus block reduced pain at rest in the early postoperative period. EDITOR’S PERSPECTIVE:

Indexed as

Anesthetics, LocalBrachial Plexus BlockBupivacaineClavicleLiposomesAdultAgedDouble-Blind MethodFemaleHumansMaleMiddle AgedPain MeasurementPostoperative PainAnesthetics, LocalBupivacaineLiposomes

Identifiers

PMID38696340
PMCPMC11389883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.